Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hypothermic Kidney Machine Perfusion With Omnisol
Sponsor: Vivalyx GmbH
Summary
Insufficient availability of organs from brain dead (DBD) and living donors has necessitated increased use of less than optimal organs from donation after cardiac death (DCD) or from extended criteria donors. Preservation of DCD organs using the current clinically applied preservation solutions is associated with up to 73% incidence of delayed graft function, highlighting the need for new preservation solutions designed to improve early graft function. Omnisol is expected to result in equivalent or improved kidney preservation as compared to currently marketed organ preservation solutions used for HMP.
Official title: A Single-Center, Non-Randomized Safety Study on Hypothermic Machine Perfusion With Omnisol Preservation Solution of Deceased Donor Kidneys Prior to Transplantation
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2027-01
Completion Date
2028-05
Last Updated
2026-11-10
Healthy Volunteers
No
Conditions
Interventions
Omnisol organ preservation solution
Omnisol for HMP of DBD or DCD donors.